MedPath

Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome(Diarrhea Type)

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Traditional Chinese Medicine
Interventions
Registration Number
NCT00948870
Lead Sponsor
Shanghai University of Traditional Chinese Medicine
Brief Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Shugan decoction on irritable bowel syndrome(diarrhea type).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Clinical diagnosis of irritable bowel syndrome(diarrhea type)
  • Male of female patients between 18-65 years old
  • Written informed consent
Exclusion Criteria
  • Discrepancy of irritable bowel syndrome
  • Diarrhea-type of irritable bowel syndrome combine with intestinal disease
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Shugan DecoctionShugan decoction-
low does of Shugan decoctionShugan decoction-
Primary Outcome Measures
NameTimeMethod
Symptoms and conditions of tongue and pulse4 weeks
Secondary Outcome Measures
NameTimeMethod
Indicates of liver and renal function4 weeks

Trial Locations

Locations (1)

Longhua hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath